VolitionRx Limited (VNRX) CEO Cameron Reynolds on Q2 2022 Results - Earnings Call Transcript

VolitionRx Limited (NYSE:NYSE:VNRX) Q2 2022 Earnings Conference Call August 11, 2022 08:30 AM ET Company Participants Scott Powell - IR Cameron Reynolds - CEO Dr.

Related Keywords

New York ,United States ,Texas ,Singapore ,Belgium ,Scott Powell ,Nathan Weinstein ,Wilson Robles ,Andrew Aswani ,Sharon Ballesteros ,Gaetan Michel ,Bruce Jackson ,Steven Ralston ,Cameron Reynolds ,Ross Osborn ,Tom Butera ,Terig Hughes ,Kevin Wilson ,Company Participants ,Volitionrx Limited ,United Veterinary Health ,Texasam University ,Veterinary Cancer Society ,International Society On Thrombosis ,Drug Administration ,Welcome To Volitionrx Limited Second Quarter ,Exchange Commission ,American College Of Veterinary Internal Medicine ,Cantor Fitzgerald ,University Of Namur ,Heska Corporation ,Ethos Discovery Group ,European Society Of Veterinary Oncology Congress ,Conference Call August ,Second Quarter ,Executive Vice President ,Chief Executive Officer ,Volition Veterinary ,Chief Financial ,Private Securities Litigation Reform Act ,Chief Financial Officer ,Volition Vet ,Neutrophil Extracellular Traps ,Capital Markets Day ,Nucleosome Biomarkers ,Septic Shock ,International Society ,Diagnostics Oncology ,United States Food ,European Society ,Veterinary Oncology Congress ,American College ,Veterinary Internal Medicine ,Southeast Asia ,